Archives: 2020-03-21

Over 24,000 coronavirus research papers are now available in one place

The data set aims to accelerate scientific research that could fight the Covid-19 pandemic. Today researchers collaborating across several organizations released the Covid-19 Open Research Dataset (CORD-19), which includes over 24,000 research papers from peer-reviewed journals as well as sources like bioRxiv and medRxiv (websites where scientists can post non-peer-reviewed preprint papers). The research covers

Read More


A new paper on Nature by The Scripps Research Institute researchers clearly show that SARS-CoV-2 is not a laboratory construct or a purposefully manipulated virus.

Since the first reports of novel pneumonia (COVID-19) in Wuhan, Hubei province, China, there has been considerable discussion on the origin of the causative virus, SARS-CoV-2 (also referred to as HCoV-19). Infections with SARS-CoV-2 are now widespread, and as of 17 March 2020, 190,664 cases have been confirmed in more than 155 countries, with 7,519 deaths.

Read More


Researchers working at the drug centre for Covid-19 cure at a company in Wuqing District report new progress in drug, therapies against Covid-19

China has completed the clinical research of Favipiravir, an antiviral drug that has shown good clinical efficacy against the Covid-19 (coronavirus) outbreak, according to an official today Favipiravir, the influenza drug which was approved for clinical use in Japan in 2014, has shown no obvious adverse reactions in the clinical trial, said Zhang Xinmin, director

Read More